What Is Synthetic Lethality?
Learn about synthetic lethality and approved drugs that use this approach to treat cancer.
Progress Against Cancer
Learn about synthetic lethality and approved drugs that use this approach to treat cancer.
Young adults often ignore telltale signs of colorectal cancer, and more evidence supports active surveillance for low-risk prostate cancer.
The CAR T-cell therapy is now approved for some patients with relapsed/refractory mantle cell lymphoma. The U.S. Food and Drug Administration (FDA) has approved lisocabtagene maraleucel (Breyanzi) for the treatment of adult patients with...
Aspirin appears to activate an immune response against colorectal cancer in the early stages of the disease.
The FDA approved the RET inhibitor selpercatinib for children with thyroid cancer and other solid tumors harboring various RET alterations. The U.S. Food and Drug Administration (FDA) has granted accelerated approval to selpercatinib (Retevmo)...
The journey to the first approved TIL therapy began with Steven A. Rosenberg over 30 years ago.
New immunotherapy approved for small cell lung cancer, and researchers investigate using urine tests to detect cancer.
The editors of AACR's journals highlight studies from May, including machine learning, savings from quitting smoking, and more.
Less frequent HPV tests detect precancerous lesions of the cervix just as well as more frequent Pap smears, which could help achieve The goal of eliminating the cancer. When it comes to detecting precancerous...
Researchers at the AACR Annual Meeting 2024 examined new treatment options for brain tumors.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More